* Prothena Corporation PLC PRTA.OQ PRTA.O is expected
to show
a rise in quarterly revenue when it reports results on February
13 (estimated).
* The Dublin Ireland; Republic of-based company is
expected to
report a 2,386.7% increase in revenue to $29.144 million from
$1.17 million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prothena
Corporation PLC
is for a loss of 47 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prothena
Corporation PLC is $81, above its last closing price
of $53.38.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.53 -0.53 -0.97 Missed -83.5
Jun. 30 2022 -0.58 -0.52 -0.88 Missed -68.1
Mar. 31 2022 -0.75 -0.68 -0.78 Missed -15.3
Dec. 31 2021 -0.59 -0.58 -0.71 Missed -21.6
Sep. 2.28 2.28 2.13 Missed -6.5
30 2021
Jun. 30 2021 1.69 1.00 0.58 Missed -41.9
Mar. 31 2021 -0.69 -0.54 -0.91 Missed -67.9
Dec. 31 2020 -0.81 -0.77 -0.77 Met -0.1
This summary was machine generated February 11 at 01:27 GMT.
All figures in US dollars unless otherwise stated